Search

Your search keyword '"Matej Orešič"' showing total 248 results

Search Constraints

Start Over You searched for: Author "Matej Orešič" Remove constraint Author: "Matej Orešič" Language english Remove constraint Language: english
248 results on '"Matej Orešič"'

Search Results

1. Concordant inter-laboratory derived concentrations of ceramides in human plasma reference materials via authentic standards

2. Identification and validation of a blood- based diagnostic lipidomic signature of pediatric inflammatory bowel disease

3. Serum lipidome associates with neuroimaging features in patients with traumatic brain injury

4. Metabolic and phenotypic changes induced by PFAS exposure in two human hepatocyte cell models

5. Exposure to environmental toxicants is associated with gut microbiome dysbiosis, insulin resistance and obesity

6. Serum APOC1 levels are decreased in young autoantibody positive children who rapidly progress to type 1 diabetes

7. Deep learning facilitates multi-data type analysis and predictive biomarker discovery in cancer precision medicine

8. Permutation-based significance analysis reduces the type 1 error rate in bisulphite sequencing data analysis of human umbilical cord blood samples

9. Circulating metabolic signatures of rapid and slow progression to type 1 diabetes in islet autoantibody-positive children

10. Impact of exposure to per- and polyfluoroalkyl substances on fecal microbiota composition in mother-infant dyads

11. Serum metabolome associated with severity of acute traumatic brain injury

12. Cord serum metabolic signatures of future progression to immune-mediated diseases

14. Integrating Omics Data in Genome-Scale Metabolic Modeling: A Methodological Perspective for Precision Medicine

15. Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver disease

16. Conjugated C-6 hydroxylated bile acids in serum relate to human metabolic health and gut Clostridia species

17. Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease

18. Impact of Extensively Hydrolyzed Infant Formula on Circulating Lipids During Early Life

19. Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance

20. Dynamics of the Lipidome in a Colon Simulator

21. Exposure to per- and polyfluoroalkyl substances associates with an altered lipid composition of breast milk

22. Potential Transdiagnostic Lipid Mediators of Inflammatory Activity in Individuals With Serious Mental Illness

23. Lipidomic Analyses Reveal Modulation of Lipid Metabolism by the PFAS Perfluoroundecanoic Acid (PFUnDA) in Non-Obese Diabetic Mice

24. Prenatal exposure to perfluoroalkyl substances modulates neonatal serum phospholipids, increasing risk of type 1 diabetes

25. 4β-Hydroxycholesterol Signals From the Liver to Regulate Peripheral Cholesterol Transporters

26. Glycomic and Glycoproteomic Techniques in Neurodegenerative Disorders and Neurotrauma: Towards Personalized Markers

27. MS-based lipidomics of human blood plasma: a community-initiated position paper to develop accepted guidelines1

28. Lipidomic and Metabolomic Signature of Progression of Chronic Kidney Disease in Patients with Severe Obesity

29. Linking Gut Microbiome and Lipid Metabolism: Moving beyond Associations

30. Human Serum Metabolites Associate With Severity and Patient Outcomes in Traumatic Brain Injury

31. Interaction between dietary lipids and gut microbiota regulates hepatic cholesterol metabolism1[S]

32. Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease

33. Metabolic Signatures of the Exposome—Quantifying the Impact of Exposure to Environmental Chemicals on Human Health

34. Targeted Serum Metabolite Profiling Identifies Metabolic Signatures in Patients with Alzheimer's Disease, Normal Pressure Hydrocephalus and Brain Tumor

35. Perspectives on Systems Modeling of Human Peripheral Blood Mononuclear Cells

36. Metabolomics Profiling As a Diagnostic Tool in Severe Traumatic Brain Injury

37. Targeted Clinical Metabolite Profiling Platform for the Stratification of Diabetic Patients

38. Metabolic Modeling of Human Gut Microbiota on a Genome Scale: An Overview

39. Obesity and psychotic disorders: uncovering common mechanisms through metabolomics

40. Accelerated renal disease is associated with the development of metabolic syndrome in a glucolipotoxic mouse model

41. Composition and lipid spatial distribution of HDL particles in subjects with low and high HDL-cholesterol[S]

42. The gut microbiota modulates host energy and lipid metabolism in mice[S]

43. Gender‐dependent progression of systemic metabolic states in early childhood

44. Roux-en-Y Gastric Bypass Surgery Induces Early Plasma Metabolomic and Lipidomic Alterations in Humans Associated with Diabetes Remission.

45. The Metabolome in Finnish Carriers of the MYBPC3-Q1061X Mutation for Hypertrophic Cardiomyopathy.

46. The gut microbiota modulates glycaemic control and serum metabolite profiles in non-obese diabetic mice.

47. Effects of whole grain, fish and bilberries on serum metabolic profile and lipid transfer protein activities: a randomized trial (Sysdimet).

48. Mondo/ChREBP-Mlx-regulated transcriptional network is essential for dietary sugar tolerance in Drosophila.

49. Associations between the human intestinal microbiota, Lactobacillus rhamnosus GG and serum lipids indicated by integrated analysis of high-throughput profiling data

50. Integrated model of metabolism and autoimmune response in β-cell death and progression to type 1 diabetes.

Catalog

Books, media, physical & digital resources